Results 1 to 10 of about 76,979 (321)

Use of Procalcitonin and C-Reactive Protein to Evaluate Vaccine Efficacy against Pneumonia [PDF]

open access: yesPLoS Medicine, 2005
BACKGROUND: Pneumonia remains the leading cause of death in young children. The poor specificity of chest radiographs (CXRs) to diagnose pneumococcal pneumonia may underestimate the efficacy of pneumococcal conjugate vaccine in preventing pneumococcal ...
Heera, Jayvant R   +3 more
core   +6 more sources

Genetic diversity of Streptococcus pneumoniae causing meningitis and sepsis in Singapore during the first year of PCV7 implementation. [PDF]

open access: yesEmerging Microbes and Infections, 2014
Streptococcus pneumoniae is a major cause of sepsis, meningitis and respiratory disease worldwide. Pneumococcal conjugate vaccines (PCVs) have now been implemented in many countries worldwide, including Singapore.
Charles Clarke, Stuart   +5 more
core   +4 more sources

Recommendation for use of the newly introduced pneumococcal protein conjugate vaccines in Korea [PDF]

open access: yesKorean Journal of Pediatrics, 2011
Streptococcus pneumoniae remains a leading cause of invasive infections including bacteremia and meningitis, as well as mucosal infections such as otitis media and pneumonia among children and adults.
Byung Wook Eun   +22 more
core   +5 more sources

Multi-serotype pneumococcal nasopharyngeal carriage prevalence in vaccine naïve Nepalese children, assessed using molecular serotyping. [PDF]

open access: yes, 2015
Invasive pneumococcal disease is one of the major causes of death in young children in resource poor countries. Nasopharyngeal carriage studies provide insight into the local prevalence of circulating pneumococcal serotypes.
Adhikari, N   +12 more
core   +21 more sources

A Trial of a 7-Valent Pneumococcal Conjugate Vaccine in HIV-Infected Adults. [PDF]

open access: yes, 2010
BACKGROUND: Streptococcus pneumoniae is a leading and serious coinfection in adults with human immunodeficiency virus (HIV) infection, particularly in Africa.
French, N   +9 more
core   +2 more sources

Pneumococcal Conjugate Vaccines and Otitis Media [PDF]

open access: yesInternational Journal of Otolaryngology, 2012
In a recent review published in International Journal of Otolaryngology, Fletcher and Fritzell provide a comprehensive and useful summary of the clinical trials assessing efficacy of pneumococcal conjugate vaccines (PCVs) against otitis media (OM) [1]. Although the Results section of the review is limited to clinical trial data, the Discussion section ...
S. Taylor   +4 more
openaire   +5 more sources

Pneumococcal Disease in the Era of Pneumococcal Conjugate Vaccine [PDF]

open access: yesInfectious Disease Clinics of North America, 2015
Universal immunization of infants and toddlers with pneumococcal conjugate vaccines over the last 15 years has dramatically altered the landscape of pneumococcal disease. Decreases in invasive pneumococcal disease, all-cause pneumonia, empyema, mastoiditis, acute otitis media, and complicated otitis media have been reported from multiple countries in ...
Inci Yildirim   +3 more
openaire   +3 more sources

Effect of Pneumococcal Conjugate Vaccine on Pneumococcal Meningitis [PDF]

open access: yesNew England Journal of Medicine, 2009
Invasive pneumococcal disease declined among children and adults after the introduction of the pediatric heptavalent pneumococcal conjugate vaccine (PCV7) in 2000, but its effect on pneumococcal meningitis is unclear.We examined trends in pneumococcal meningitis from 1998 through 2005 using active, population-based surveillance data from eight sites in
Matthew R. Moore   +15 more
openaire   +3 more sources

Challenges in estimating the impact of pneumococcal conjugate vaccines through surveillance [PDF]

open access: yes, 2012
SCOPUS: re.jinfo:eu-repo/semantics ...
Hanquet, Germaine, Vergison, Anne
core   +1 more source

Nasopharyngeal S. pneumoniae carriage and density in Belgian infants after 9 years of pneumococcal conjugate vaccine programme [PDF]

open access: yes, 2018
Background: In Belgium, the infant pneumococcal conjugate vaccine (PCV) programme changed from PCV7 (2007-2011) to PCV13 (2011-2015) and to PCV10 (2015-2016). A 3-year nasopharyngeal carriage study was initiated during the programme switch in 2016.
Blaizot, Stéphanie   +10 more
core   +2 more sources

Home - About - Disclaimer - Privacy